These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 18715846

  • 1. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
    Feng W, Brown RE, Trung CD, Li W, Wang L, Khoury T, Alrawi S, Yao J, Xia K, Tan D.
    Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
    [Abstract] [Full Text] [Related]

  • 2. Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates.
    Brown RE, Tan D, Taylor JS, Miller M, Prichard JW, Kott MM.
    Ann Clin Lab Sci; 2007; 37(2):141-7. PubMed ID: 17522369
    [Abstract] [Full Text] [Related]

  • 3. Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma.
    Brown RE, Zhang PL, Lun M, Zhu S, Pellitteri PK, Riefkohl W, Law A, Wood GC, Kennedy TL.
    Ann Clin Lab Sci; 2006; 36(3):273-82. PubMed ID: 16951268
    [Abstract] [Full Text] [Related]

  • 4. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [Abstract] [Full Text] [Related]

  • 5. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.
    Lin F, Zhang PL, Yang XJ, Prichard JW, Lun M, Brown RE.
    Ann Clin Lab Sci; 2006 Jan; 36(3):283-93. PubMed ID: 16951269
    [Abstract] [Full Text] [Related]

  • 6. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S, Meng Q, Laterra JJ, Rosen EM.
    Oncogene; 2007 Jul 19; 26(33):4774-96. PubMed ID: 17297451
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
    Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, Ramon y Cajal S.
    Cancer; 2006 Oct 15; 107(8):1801-11. PubMed ID: 16983702
    [Abstract] [Full Text] [Related]

  • 8. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
    Ahmed KM, Dong S, Fan M, Li JJ.
    Mol Cancer Res; 2006 Dec 15; 4(12):945-55. PubMed ID: 17189385
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.
    Pervin S, Singh R, Hernandez E, Wu G, Chaudhuri G.
    Cancer Res; 2007 Jan 01; 67(1):289-99. PubMed ID: 17210710
    [Abstract] [Full Text] [Related]

  • 10. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H, Wierenga AT, Eggen BJ, Vellenga E.
    Exp Hematol; 2005 Jul 01; 33(7):747-57. PubMed ID: 15963850
    [Abstract] [Full Text] [Related]

  • 11. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ, Brown G.
    J Cell Biochem; 2006 Jun 01; 98(3):590-617. PubMed ID: 16440327
    [Abstract] [Full Text] [Related]

  • 12. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
    López-Pedrera C, Buendía P, Cuadrado MJ, Siendones E, Aguirre MA, Barbarroja N, Montiel-Duarte C, Torres A, Khamashta M, Velasco F.
    Arthritis Rheum; 2006 Jan 01; 54(1):301-11. PubMed ID: 16385547
    [Abstract] [Full Text] [Related]

  • 13. Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.
    Quesada AE, Nguyen ND, Rios A, Brown RE.
    Int J Clin Exp Pathol; 2014 Jan 01; 7(12):8732-9. PubMed ID: 25674239
    [Abstract] [Full Text] [Related]

  • 14. Morphoproteomics demonstrates activation of mTOR pathway in anaplastic thyroid carcinoma: a preliminary observation.
    Liu J, Brown RE.
    Ann Clin Lab Sci; 2010 Jan 01; 40(3):211-7. PubMed ID: 20689131
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
    Chen S, Nakahara T, Uchi H, Takeuchi S, Takahara M, Kido M, Dugu L, Tu Y, Moroi Y, Furue M.
    Br J Dermatol; 2009 Aug 01; 161(2):357-63. PubMed ID: 19438435
    [Abstract] [Full Text] [Related]

  • 16. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
    Baek MK, Kim MH, Jang HJ, Park JS, Chung IJ, Shin BA, Ahn BW, Jung YD.
    Oncol Rep; 2008 Dec 01; 20(6):1569-75. PubMed ID: 19020743
    [Abstract] [Full Text] [Related]

  • 17. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.
    Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M, Katano M.
    Clin Cancer Res; 2001 Dec 01; 7(12):4136-42. PubMed ID: 11751513
    [Abstract] [Full Text] [Related]

  • 18. mTOR and P70 S6 kinase expression in primary liver neoplasms.
    Sahin F, Kannangai R, Adegbola O, Wang J, Su G, Torbenson M.
    Clin Cancer Res; 2004 Dec 15; 10(24):8421-5. PubMed ID: 15623621
    [Abstract] [Full Text] [Related]

  • 19. Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease.
    Lin N, Uchi H, Moroi Y, Fukiwake N, Dainichi T, Takeuchi S, Takahara M, Tu Y, Furue M, Urabe K.
    J Dermatol Sci; 2007 Mar 15; 45(3):187-92. PubMed ID: 17207971
    [Abstract] [Full Text] [Related]

  • 20. Differential requirement of signal pathways for benzo[a]pyrene (B[a]P)-induced nitric oxide synthase (iNOS) in rat esophageal epithelial cells.
    Chen J, Yan Y, Li J, Ma Q, Stoner GD, Ye J, Huang C.
    Carcinogenesis; 2005 Jun 15; 26(6):1035-43. PubMed ID: 15718251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.